A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Cmax / maximum concentration

[Related PubMed/MEDLINE]
Total Number of Papers: 24
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Cmax  (>> Co-occurring Abbreviation)
Long Form:   maximum concentration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial. AUC24, C min, mTOR
2017 A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects. PK
2016 Comparative Plasma and Cerebrospinal Fluid Pharmacokinetics of Paracetamol After Intravenous and Oral Administration. AUCs, CIs, CSF, Tmax
2016 In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters. AUC, DDIs, SURI
2016 Overview of extended release tacrolimus in solid organ transplantation. Tmax
2016 Preparation and In Vivo Pharmacokinetics of the Tongshu Suppository. APS
2016 The comparison of humeral intraosseous and intravenous administration of vasopressin on return of spontaneous circulation and pharmacokinetics in a hypovolemic cardiac arrest swine model. ACLS, AHA, CPR, HIO, IO, MANOVA, ROSC, Tmax
2015 Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects. AUC, CI, ER, MDD
2015 Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. AEs, PPQ, QTcB, QTcF
10  2014 Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally). AUCpo, NYHA
11  2014 Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers. ---
12  2014 The metabolism of YiGan San and subsequent pharmacokinetic evaluation of four metabolites in rat based on liquid chromatography with tandem mass spectrometry. YGS
13  2013 Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations. AEs, CI, ECGs, HVD, IR, MRT, PR
14  2013 Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers. AUC
15  2012 Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial. EE, LV
16  2004 The interaction of the diltiazem with oral and intravenous cyclosporine in rats. AUC
17  2003 Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits. L-Nys
18  2001 Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats. HMAP, PD, PK, s.c, s.i
19  1999 Galenic development and pharmacokinetic profile of indapamide sustained release 1.5 mg. IR, MHPC, SR
20  1999 Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens. i.v, IM, Tmax
21  1997 Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior. AUC, TID
22  1995 Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. AUC, CL, MRT, Vdss
23  1993 Evaluation of the bioequivalence of tablet and capsule formulations of granisetron in patients undergoing cytotoxic chemotherapy for malignant disease. AUC
24  1990 Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects. ---